Agilent Technologies Free Cash Flow 2010-2025 | A
Agilent Technologies annual/quarterly free cash flow history and growth rate from 2010 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Agilent Technologies free cash flow for the quarter ending April 30, 2025 was 334.00, a year-over-year.
- Agilent Technologies free cash flow for the twelve months ending April 30, 2025 was , a year-over-year.
- Agilent Technologies annual free cash flow for 2024 was $1.373B, a 6.85% decline from 2023.
- Agilent Technologies annual free cash flow for 2023 was $1.474B, a 44.37% increase from 2022.
- Agilent Technologies annual free cash flow for 2022 was $1.021B, a 21.34% decline from 2021.
| Agilent Technologies Annual Free Cash Flow | |
|---|---|
| 2024 | 1,373.00 |
| 2023 | 1,474.00 |
| 2022 | 1,021.00 |
| 2021 | 1,298.00 |
| 2020 | 803.00 |
| 2019 | 866.00 |
| 2018 | 911.00 |
| 2017 | 713.00 |
| 2016 | 654.00 |
| 2015 | 426.00 |
| 2014 | 540.00 |
| 2013 | 959.00 |
| 2012 | 1,034.00 |
| 2011 | 1,090.00 |
| 2010 | 604.00 |
| 2009 | 281.00 |
| Agilent Technologies Quarterly Free Cash Flow | |
|---|---|
| 2025-01-31 | 334.00 |
| 2024-10-31 | 1,373.00 |
| 2024-07-31 | 985.00 |
| 2024-04-30 | 625.00 |
| 2024-01-31 | 395.00 |
| 2023-10-31 | 1,474.00 |
| 2023-07-31 | 1,042.00 |
| 2023-04-30 | 561.00 |
| 2023-01-31 | 220.00 |
| 2022-10-31 | 1,021.00 |
| 2022-07-31 | 643.00 |
| 2022-04-30 | 399.00 |
| 2022-01-31 | 180.00 |
| 2021-10-31 | 1,298.00 |
| 2021-07-31 | 918.00 |
| 2021-04-30 | 638.00 |
| 2021-01-31 | 197.00 |
| 2020-10-31 | 803.00 |
| 2020-07-31 | 453.00 |
| 2020-04-30 | 187.00 |
| 2020-01-31 | -93.00 |
| 2019-10-31 | 866.00 |
| 2019-07-31 | 582.00 |
| 2019-04-30 | 387.00 |
| 2019-01-31 | 174.00 |
| 2018-10-31 | 911.00 |
| 2018-07-31 | 574.00 |
| 2018-04-30 | 410.00 |
| 2018-01-31 | 155.00 |
| 2017-10-31 | 713.00 |
| 2017-07-31 | 483.00 |
| 2017-04-30 | 298.00 |
| 2017-01-31 | 84.00 |
| 2016-10-31 | 654.00 |
| 2016-07-31 | 472.00 |
| 2016-04-30 | 302.00 |
| 2016-01-31 | 73.00 |
| 2015-10-31 | 426.00 |
| 2015-07-31 | 211.00 |
| 2015-04-30 | 122.00 |
| 2015-01-31 | -52.00 |
| 2014-10-31 | 540.00 |
| 2014-07-31 | 399.00 |
| 2014-04-30 | 423.00 |
| 2014-01-31 | 149.00 |
| 2013-10-31 | 959.00 |
| 2013-07-31 | 614.00 |
| 2013-04-30 | 452.00 |
| 2013-01-31 | 187.00 |
| 2012-10-31 | 1,034.00 |
| 2012-07-31 | 611.00 |
| 2012-04-30 | 420.00 |
| 2012-01-31 | 104.00 |
| 2011-10-31 | 1,090.00 |
| 2011-07-31 | 629.00 |
| 2011-04-30 | 409.00 |
| 2011-01-31 | 82.00 |
| 2010-10-31 | 604.00 |
| 2010-07-31 | 265.00 |
| 2010-04-30 | 202.00 |
| 2010-01-31 | 5.00 |
| 2009-10-31 | 281.00 |
| 2009-07-31 | 97.00 |
| 2009-04-30 | 86.00 |
| 2009-01-31 | -17.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $33.258B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.957B | 28.37 |
| Boston Scientific (BSX) | United States | $147.560B | 36.94 |
| Stryker (SYK) | United States | $144.011B | 30.11 |
| EssilorLuxottica (ESLOY) | France | $128.708B | 0.00 |
| Medtronic (MDT) | Ireland | $111.928B | 15.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.371B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.904B | 27.87 |
| ResMed (RMD) | United States | $36.560B | 27.46 |
| GE HealthCare Technologies (GEHC) | United States | $33.082B | 15.71 |
| Terumo (TRUMY) | Japan | $26.680B | 34.65 |
| Insulet (PODD) | United States | $21.438B | 84.15 |
| Koninklijke Philips (PHG) | Netherlands | $21.384B | 15.37 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.060B | 11.60 |
| Baxter (BAX) | United States | $15.713B | 11.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.872B | 0.00 |
| Demant (WILYY) | Denmark | $9.377B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.175B | 21.49 |
| Lantheus Holdings (LNTH) | United States | $5.385B | 13.58 |
| Prestige Consumer Healthcare (PBH) | United States | $4.149B | 18.54 |
| Perrigo (PRGO) | Ireland | $3.664B | 9.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.367B | 15.34 |
| ICU Medical (ICUI) | United States | $3.250B | 23.96 |
| Envista Holdings (NVST) | United States | $3.127B | 25.99 |
| GN Store Nord (GNNDY) | Denmark | $2.263B | 18.74 |
| QuidelOrtho (QDEL) | United States | $1.954B | 13.44 |
| LeMaitre Vascular (LMAT) | United States | $1.833B | 40.97 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Acuren (TIC) | United States | $1.357B | 0.00 |
| Neogen (NEOG) | United States | $1.200B | 15.36 |
| AdaptHealth (AHCO) | United States | $1.161B | 11.78 |
| Green Thumb Industries (GTBIF) | United States | $1.048B | 23.58 |
| BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.970B | 12.40 |
| Kestra Medical Technologies (KMTS) | United States | $0.904B | 0.00 |
| InMode (INMD) | Israel | $0.844B | 8.51 |
| Evolus (EOLS) | United States | $0.640B | 0.00 |
| CeriBell (CBLL) | United States | $0.624B | 0.00 |
| Owens & Minor (OMI) | United States | $0.602B | 4.99 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.538B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.524B | 0.00 |
| Valneva SE (VALN) | France | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.407B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.337B | 12.41 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.329B | 58.50 |
| Canopy Growth (CGC) | Canada | $0.272B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.263B | 22.17 |
| Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.254B | 0.00 |
| ZimVie (ZIMV) | United States | $0.253B | 11.52 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.245B | 0.00 |
| Quanterix (QTRX) | United States | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.207B | 5.82 |
| Brainsway (BWAY) | Israel | $0.206B | 54.50 |
| Omeros (OMER) | United States | $0.199B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Organigram Global (OGI) | Canada | $0.187B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.59 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Exagen (XGN) | United States | $0.152B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.140B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 0.00 |
| Jin Medical (ZJYL) | China | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.64 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Agape ATP (ATPC) | $0.084B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.29 |
| United-Guardian (UG) | United States | $0.037B | 12.90 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.019B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Safety Shot (SHOT) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.012B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |